Skip to main content

Table 2 Multivariable linear regression of factors associated with PMI at follow-up CT scan, N = 474. Reference values for continuous variables are their 75th and 25th percentiles

From: Impact of pectoralis muscle loss on cardiac outcome and survival in Cancer patients who received anthracycline based chemotherapy: retrospective study

Characteristic

Geometric mean ratio

95% CI

P-value

PMI at baseline [7.7 vs 4.9]

1.32

1.25, 1.40

< 0.01

Age at baseline [67 vs. 53]

0.93

0.87, 0.99

0.01

Years from chemotherapy to follow-up CT [0.6 vs 0.2]

1.03

0.97, 1.09

0.44

Stage

  

0.91

 I or II

1 (Ref.)

  

 III or IV

1.00

0.95, 1.05

 

 Unknown

1.04

0.95, 1.14

 

Smoking history

  

< 0.01

 Never

1 (Ref.)

  

 Ever

0.94

0.91, 0.98

 

Sex

  

< 0.01

 Female

1 (Ref.)

  

 Male

1.12

1.06, 1.20

 

Cancer Type

  

0.19

 Breast

1 (Ref.)

  

 Lymphoma

1.00

0.93, 1.07

 

 Sarcoma

0.95

0.88, 1.02

 

Treatment

  

0.64

 Anthracyclines

1 (Ref.)

  

 Trastuzumab

1.04

0.96, 1.12

 

 Both

1.01

0.93, 1.09